Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Darcey Steinke wanted to write a book that wasn’t just about trying to get over pain. Her memoir, This Is the Door, explores how chronic pain changes us ...
Lynxkite is expanding its partnership with Biophytis SA (Euronext Growth Paris: ALBPS) ("Biophytis"), starting with the MASSIVE project (MAS Receptor Synthetic Innovation & Virtual Engineering for ...
Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...
About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
Bruce Campbell, known for his role as Ash Williams in Sam Raimi's Evil Dead franchise, said he's been diagnosed with a "type ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:50 AM ESTCompany ParticipantsLarry Wood - President, ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...
No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results